[go: up one dir, main page]

NO840952L - Fremgangsmaate til fremstilling av et humant interferon-gamma-polypeptid, rekombinant plasmid omfattende et dna-fragment som koder for peptidet, og mikroorganisme transfermert med plasmidet - Google Patents

Fremgangsmaate til fremstilling av et humant interferon-gamma-polypeptid, rekombinant plasmid omfattende et dna-fragment som koder for peptidet, og mikroorganisme transfermert med plasmidet

Info

Publication number
NO840952L
NO840952L NO840952A NO840952A NO840952L NO 840952 L NO840952 L NO 840952L NO 840952 A NO840952 A NO 840952A NO 840952 A NO840952 A NO 840952A NO 840952 L NO840952 L NO 840952L
Authority
NO
Norway
Prior art keywords
plasmid
peptid
procedure
preparation
dna fragment
Prior art date
Application number
NO840952A
Other languages
English (en)
Other versions
NO169020C (no
NO169020B (no
Inventor
Seiga Itoh
Tatsunari Nishi
Tadatsugu Taniguchi
Haruo Sugano
Original Assignee
Kyowa Hakko Kogyo Kk
Japan Found Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26381690&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO840952(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk, Japan Found Cancer filed Critical Kyowa Hakko Kogyo Kk
Publication of NO840952L publication Critical patent/NO840952L/no
Publication of NO169020B publication Critical patent/NO169020B/no
Publication of NO169020C publication Critical patent/NO169020C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/71Expression systems using regulatory sequences derived from the trp-operon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
NO840952A 1983-03-14 1984-03-13 Rekombinant plasmid og fremgangsmaate for fremstilling av et humant interferon-gamma-polypeptid NO169020C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58042042A JPH0740925B2 (ja) 1983-03-14 1983-03-14 新規ヒトインタ−フエロン−γポリペプチド
JP4207840A JPH05320200A (ja) 1983-03-14 1992-08-04 新規ヒトインターフェロン−γポリペプチド

Publications (3)

Publication Number Publication Date
NO840952L true NO840952L (no) 1984-09-17
NO169020B NO169020B (no) 1992-01-20
NO169020C NO169020C (no) 1992-04-29

Family

ID=26381690

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840952A NO169020C (no) 1983-03-14 1984-03-13 Rekombinant plasmid og fremgangsmaate for fremstilling av et humant interferon-gamma-polypeptid

Country Status (6)

Country Link
EP (1) EP0121157B1 (no)
JP (2) JPH0740925B2 (no)
AU (1) AU2561984A (no)
DK (1) DK160945C (no)
ES (1) ES8506194A1 (no)
NO (1) NO169020C (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
YU32402A (sh) 1999-11-12 2005-03-15 Maxygen Holdings Ltd. Konjugati gama interferona
BR0015506A (pt) 1999-11-12 2002-07-23 Maxygen Holdings Ltd Conjugados de interferon gama, métodos para sua preparação, composições farmacêuticas que compreendem ás moléculas e seu uso no tratamento de doenças
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US7524931B2 (en) 2002-07-03 2009-04-28 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
WO2014168064A1 (ja) 2013-04-10 2014-10-16 国立大学法人浜松医科大学 Lix1l高発現腫瘍細胞の増殖阻害方法、及び腫瘍細胞増殖抑制ペプチド

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
JPS58110600A (ja) * 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4582800A (en) * 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression
IL69851A0 (en) * 1982-09-30 1983-12-30 Japan Found Cancer Novel dna and recombinant plasmid containing the same

Also Published As

Publication number Publication date
AU2561984A (en) 1984-09-20
DK155184A (da) 1984-09-15
DK160945B (da) 1991-05-06
ES530597A0 (es) 1985-07-01
JPS59167596A (ja) 1984-09-21
JPH05320200A (ja) 1993-12-03
ES8506194A1 (es) 1985-07-01
EP0121157B1 (en) 1989-06-14
EP0121157A1 (en) 1984-10-10
DK155184D0 (da) 1984-03-13
NO169020C (no) 1992-04-29
DK160945C (da) 1991-10-21
NO169020B (no) 1992-01-20
JPH0740925B2 (ja) 1995-05-10

Similar Documents

Publication Publication Date Title
NO861847L (no) Keramiske kuler og fremgangsmaate til deres fremstilling.
FI873570A7 (fi) Peptidivalmiste, menetelmä sen valmistamiseksi ja sen käyttö.
EP0239631A4 (en) RECOMBINANT APOLIPOPROTEINS AND METHODS.
DK324386A (da) Substitueret androsta-1,4-dien-3,17-dion og fremgangsmaade til fremstilling deraf
NO176799C (no) DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid
DK0962531T3 (da) Interferon-gammaproduktion inducerende isoleret polypeptidfragment og et isolaret DNA-fragment der koder for dette polypeptid
IL81839A0 (en) Polypeptide,dna and its use
ZA86217B (en) Dna sequences,recombinant dna molecules and processes for producing human lipocortin-like polypeptides
NO840952L (no) Fremgangsmaate til fremstilling av et humant interferon-gamma-polypeptid, rekombinant plasmid omfattende et dna-fragment som koder for peptidet, og mikroorganisme transfermert med plasmidet
DK291386D0 (da) Uorganiske oxidfibre, og fremgangsmaade til deres fremstilling
NO845132L (no) Humant interferon-ypsilon-polypeptidderivat, fremgangsmaate for fremstilling derav og rekombinant plasmid inneholdende et dna-fragment som koder for polypeptidet
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
NO165683C (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
DK495486D0 (da) Proteiner med human-gamma-interferon-aminosyredelsekvenser, deres fremstilling og anvendelse
FI863626A7 (fi) DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
NZ213249A (en) Protein antigen, dna, plasmid, transformed microorganism and influenza vaccine
DK575787A (da) Rekombinant hcmv-afledt plasmid, dets fremstilling og anvendelse
DK447083A (da) Dna, som koder for humant interferon-gamma, rekombinant-dna indeholdende denne dna, mikroorganisme indeholdende rekombinant-dna'en og fremgangsmaade til fremstilling af humant interferon-gamma-polypeptid
DK698188A (da) Peptider, deres fremstilling og anvendelse
ZA852629B (en) A peptide vaccine or diagnostic,and a polypeptide useful therefor
FI861428A7 (fi) Rekombinoitu ihmisreniini.
EP0244427A4 (en) RECOMBINANT VIRUS.
DK571986D0 (da) Dna-sekvens, rekombinant-dna og vaertsceller transformeret med sammesamt fremgangsmaade til fremstilling af human-vaevsplasminogen aktivator
DK365186D0 (da) 5-chlor-s-triazolo(4,3-a)pyridin-7-carboxylsyrer og fremgangsmaade til deres fremstilling
DK164283C (da) Polypeptid med cystatin c aktivitet, dna-sekvens til udtrykkelse af 3-des-oh-cystatin c eller en modifikation deraf, fremgangsmaade til fremstilling af 3-des-hydroxy-cystatin c eller en modifikation deraf, plasmid og mikroorganisme til udoevelse af fremgangsmaaden og anvendelse af 3-des-oh-cystatin c eller en modifikation deraf til fremstilling af et terapeutisk praeparat